Renal amyloidosis is associated with increased mortality in hemodialysis patients

被引:9
作者
Sengul, S
Arat, Z
Ozdemir, FN
机构
[1] Ankara Univ, Sch Med, Ibni Sina Hosp, Dept Nephrol, TR-06100 Ankara, Turkey
[2] Baskent Univ, Sch Med, Dept Nephrol, TR-06490 Ankara, Turkey
关键词
secondary systemic amyloidosis; diabetes mellitus; inflammation; survival; end-stage renal disease;
D O I
10.1111/j.1525-1594.2004.00063.x
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Aim: The aim of the study was to investigate the risk factors for mortality of hemodialysis (HD) patients at Baskent University Hospital, HD Center in Ankara, Turkey. Methods:We prospectively followed 203 stable HD patients for 42 months. Population characteristics (age, gender, duration of HD, causes of end stage renal disease [ESRD]) and biochemical variables were included in the study. Mortality was prospectively monitored. Results: Sixty-one patients died over 42 months. Cardiovascular events and infections/septicemia were the most common causes of death. The nonsurvivors had significantly lower hemoglobin (Hb), parathyroid hormone (PTH), creatinine, albumin, and prealbumin levels and higher age and higher C-reactive protein (CRP) levels. Survival curves as obtained by the Kaplan-Meier method in the groups of causes of ESRD (renal amyloidosis [RA], diabetes mellitus [DM], hypertension [HT] + atherosclerotic kidney disease [AKD], and others) showed that patients with DM and RA had the worst prognosis during the follow-up period. In the multivariate Cox proportional hazards model, RA and DM were found to be independent risk factors for death in HD patients together with high CRP and low albumin and prealbumin levels. Infection/septicemia is the leading cause of mortality in patients with DM and RA. Conclusion: The results of this study indicate that the presence of RA and DM as underlying renal diseases are independent predictors of mortality in our HD patients along with poor nutritional status and activated inflammatory response.
引用
收藏
页码:846 / 852
页数:7
相关论文
共 40 条
  • [1] DIALYSIS IN RENAL-FAILURE CAUSED BY AMYLOIDOSIS OF FAMILIAL MEDITERRANEAN FEVER - REPORT OF 10 CASES
    ARI, JB
    ZLOTNIK, M
    OREN, A
    BERLYNE, GM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1976, 136 (04) : 449 - 451
  • [2] Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
    Bologa, RM
    Levine, DM
    Parker, TS
    Cheigh, JS
    Serur, D
    Stenzel, KH
    Rubin, AL
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (01) : 107 - 114
  • [3] Prevalence and significance of the familial Mediterranean fever gene mutation encoding pyrin Q148
    Booth, DR
    Lachmann, HJ
    Gillmore, JD
    Booth, SE
    Hawkins, PN
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2001, 94 (10) : 527 - 531
  • [4] Brunner F P, 1992, Kidney Int Suppl, V38, pS4
  • [5] Malnutrition in hemodialysis diabetic patients: Evaluation and prognostic influence
    Cano, NJM
    Roth, H
    Aparicio, M
    Azar, R
    Canaud, B
    Chauveau, P
    Combe, C
    Fouque, D
    Laville, M
    Leverve, XM
    [J]. KIDNEY INTERNATIONAL, 2002, 62 (02) : 593 - 601
  • [6] Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease - Meta-analyses of prospective studies
    Danesh, J
    Collins, R
    Appleby, P
    Peto, R
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (18): : 1477 - 1482
  • [7] DAUGIRDAS JT, 1993, J AM SOC NEPHROL, V4, P1205
  • [8] David S, 1993, ASAIO J, V39, pM773
  • [9] Direskeneli H, 1999, J RHEUMATOL, V26, P1983
  • [10] Don BR, 2000, J NEPHROL, V13, P249